These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38849096)

  • 21. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
    Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
    Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Gold Nanoparticles: Synthesis, Functionalization Strategies, and Theranostic Applications in Cancer.
    Damani M; Jadhav M; Joshi R; Singh BP; Momin MM; Ningthoujam RS; Khan T
    Crit Rev Ther Drug Carrier Syst; 2024; 41(6):1-56. PubMed ID: 38804553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.
    Yadollahpour A
    Curr Top Med Chem; 2020; 20(27):2425-2426. PubMed ID: 33210582
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent Developments of Supramolecular Metal-based Structures for Applications in Cancer Therapy and Imaging.
    Pöthig A; Casini A
    Theranostics; 2019; 9(11):3150-3169. PubMed ID: 31244947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallic Nanoclusters for Cancer Imaging and Therapy.
    Zhang Q; Yang M; Zhu Y; Mao C
    Curr Med Chem; 2018; 25(12):1379-1396. PubMed ID: 28393695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
    Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
    Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential drug delivery nanosystems for improving tumor penetration.
    Peng F; Li R; Zhang F; Qin L; Ling G; Zhang P
    Eur J Pharm Biopharm; 2020 Jun; 151():220-238. PubMed ID: 32311427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of Multifunctional Mn
    Lu Y; Wu Y; Tang Z; Hou Y; Cui M; Huang S; Long B; Yu Z; Iqbal MZ; Kong X
    Sensors (Basel); 2023 Nov; 23(21):. PubMed ID: 37960633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging.
    Bigaj-Józefowska MJ; Coy E; Załęski K; Zalewski T; Grabowska M; Jaskot K; Perrigue P; Mrówczyński R; Grześkowiak BF
    J Photochem Photobiol B; 2023 Dec; 249():112813. PubMed ID: 37977004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
    Lungu II; Grumezescu AM; Volceanov A; Andronescu E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulation for Cancer Therapy.
    Montané X; Bajek A; Roszkowski K; Montornés JM; Giamberini M; Roszkowski S; Kowalczyk O; Garcia-Valls R; Tylkowski B
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.
    Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY
    Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Dyestuff Chemistry to Cancer Theranostics: The Rise of Rylenecarboximides.
    Ji C; Cheng W; Yuan Q; Müllen K; Yin M
    Acc Chem Res; 2019 Aug; 52(8):2266-2277. PubMed ID: 31373482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insight into the engineering of green carbon dots: Possible applications in emerging cancer theranostics.
    Radnia F; Mohajeri N; Zarghami N
    Talanta; 2020 Mar; 209():120547. PubMed ID: 31892009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy.
    Gessner I; Neundorf I
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.